Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2024 Financial Results Conference Call

Introduction

Step right up, ladies and gentlemen, and let’s dive into the exciting world of Viking Therapeutics and their latest financial results! On February 5, 2025, at 4:30 PM ET, the company held their Q4 2024 Earnings Conference Call, and it was a doozy. Our fearless leaders, CEO and President Brian Lian and CFO Greg Zante, along with IR Manager Stephanie Diaz, were in the hot seat, ready to break down the numbers and give us the inside scoop.

Conference Call Participants

Shoutout to all the professionals who took the time to join the call and ask those burning questions, including Ryan Deschner from Raymond James, Mike Ulz from Morgan Stanley, and Asim Rana from Truist Securities. We see you, Jay Olson from Oppenheimer, Annabel Samimy from Stifel, and Mayank Mamtani from B. Riley Securities. And of course, a big hello to Biren Amin from Piper Sandler, Hardik Parikh from JPMorgan, Andy Hsieh from William Blair, Yale Jen from Laidlaw & Company, and Justin Zelin from BTIG. You guys rock!

Impact on Me

As a potential investor or consumer, the results of Viking Therapeutics’ Q4 2024 Financial Results Conference Call could have a direct impact on my financial decisions. By understanding the company’s performance and future outlook, I can make informed choices about whether to invest in their products or services. It’s important to stay up-to-date on these earnings calls to stay ahead of the game!

Impact on the World

But it’s not just about me; the success (or struggles) of Viking Therapeutics can have a ripple effect on the world at large. Whether it’s through groundbreaking medical treatments, innovative technological advancements, or job creation within the industry, the influence of a company like Viking Therapeutics extends far beyond its quarterly earnings. Their contributions to the field of healthcare and biotechnology could potentially impact millions of lives around the globe.

Conclusion

So there you have it, folks – a glimpse into the world of Viking Therapeutics and the impact of their Q4 2024 Financial Results Conference Call. Whether you’re a seasoned investor, a curious consumer, or just someone interested in the latest developments in the biotech industry, these earnings calls are a valuable source of information and insight. Stay tuned for more updates and let’s keep riding the wave of innovation together!